Introduction
Human African trypanosomiasis, also known as sleeping sickness, is a vector-borne parasitic disease. The parasites concerned are protozoa belonging to the Trypanosoma genus. They are transmitted to humans by tsetse fly (Glossina genus) which have acquired their infection from human beings or from animals harbouring the human pathogenic parasites. Rural populations living in regions where transmission occurs and which depend on agriculture, fishing, animal husbandry or hunting are the most exposed to the disease. Sleeping sickness threatens millions of people in 36 countries in sub-Saharan Africa. Many of the affected populations live in remote areas with limited access to adequate health services. Treatment depends on drugs that can cross the blood-brain barrier to reach the parasite. Such drugs are toxic and complicated to administer. Suramin, discovered in 1921, is one of the drugs used for the treatment. However, it provokes certain undesirable effects, in the urinary tract and allergic reactions. Other drugs in use are equally toxic and difficult to administer. Thus the need to develop new drugs is imperative. Natural products and medicinal plants (Antia et al, 2009; Sara et al, 2004; Bizimana et al., 2006; Okpekon et al., 2004) have continued to contribute to the search for new and potent anti-trypanosomal drugs with minimal side effects. Their continued relevance in drug discovery and development is due to their bioactivity, biodiversity and reported safety in their use. An analysis of new and approved drugs for the treatment of human diseases indicated that natural products have continued to play a highly significant role in the drug discovery and development process. Thus biologically active natural products from plants, their
Materials and methods
Standard methods of extraction and isolation or purification of compounds/extracts from plant materials were used while a standardised 96 well based assay was used to screen the extracts for anti-trypanosomal activity and cytotoxicity. The crude extracts as well as pure compounds obtained were screened in vitro for trypanosomal activity against Trypanosoma brucei brucei (S427) blood stream forms. Active compounds from the preliminary screens were further tested to confirm activity and determine their minimum inhibitory concentration (MIC) values. Cytotoxicity of the active compounds and extracts was then tested against PNT2A cells ("normal" prostatic cells).
General bioassay
The anti-trypanosomal and cytotoxicity assays were performed using the REDOX indicator Alamar blue™. The active component of which is resazurin (blue in colour) which in the presence of live parasites or cells is reduced to the bright pink fluorescent resorufin. The fluorescence values for the test plates are measured using a microplate reader in fluorescence mode with excitation and emission wavelengths of 560 and 590nm respectively.
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Anti-Trypanosomal Activity and Cytotoxicity of Some Compounds and Extracts from Nigerian Medicinal Plants 377 Wells containing active compounds are easily identified as they remain blue in colour and have background levels of fluorescence. The test samples are initially screened at a single concentration and then MIC or IC 50 values are determined for the active compounds at n=2 or n=3. Positive and negative controls and a sterility checks are included in all assays. The incubation and treatment times, incubation conditions and seeding densities are optimised for each test species and cell line.
Anti-trypanosomal activity
Samples were tested against the bloodstream form of Trypanosoma brucei brucei (T.b.brucei) S427. The activity of the plant extracts and isolated compounds was determined using the well-established Alamar blue™ 96 well microplate assay. Samples were initially screened at a single concentration usually 20µg/ml for extracts or 20µM for pure compounds. The concentration of dimethylsulphoxide (DMSO) should not exceed 0.5% in the initial screen.
Samples for testing were prepared as 10mg/ml or 10mM stock solutions in 100% DMSO. These were diluted with HMI-9 medium to a concentration of 1mg/ml /1mM. 4µl of the test sample was added to the assay well then 96µl HMI-9 medium to give a final assay concentration after a 1:1 dilution of 20µg/ml / 20µM. The screening plate was arranged as illustrated in Table 1 . Controls including a sterility control and DMSO controls in column 1; test samples in columns 2 to 11 and a concentration range of suramin as a positive control in column12. Trypanosomes were counted using a haemocytometer and diluted to a concentration of 3x10 4 trypanosomes /ml, 100µl of this suspension was added to each well of the assay plate with the exception of well A1 the sterility check. The assay plate was incubated at 37ºC, 5% CO 2 with a humidified atmosphere for 48 hours. After which 20µl of Alamar blue was added and the incubation continued for a further 24 hours. Fluorescence was then determined using the Wallac Victor microplate reader (Excitation 530nm Emission 590nm). The results were calculated as % of the DMSO control values. Minimum inhibitory concentration values (MICs) were determined for samples with less than 10% of control values. MIC determinations were carried out in duplicate. 200µg/ml test solutions were prepared in column 2 by pipetting 4µl of (10mg/ml) test stock solution and 196µl HMI-9 medium into each well. 100µl HMI-9 medium was pipetted into columns 1 and 3-12 and 1:1 serial dilutions were carried out from columns 2 to 11. 80µl of HMI-9 medium was added to column 12 and 20µl of x10 concentrations of suramin to give a final concentration range of 0.008 to 1.0µM. An inoculum of 100µl of trypanosomes at a concentration of 3x10 4 /ml was added to each well except A1, and the procedure continued as previously described. Table 2 . Final assay concentrations µg/ml MIC values were determined as the concentration calculated to have < 5% of control values.
Cytotoxicity determinations
Cytotoxicity determinations were carried out using a modification the Alamar blue™ redoxbased microplate assay (O'Brien et al., 2000) . The cytotoxic activity of the fractions and compounds was initially determined against PNT2A cells a "human" normal prostatic epithelial cell line. Initial screening was carried out at a concentration of 100µg/ml. Concentration response studies (300 to 0.3µg/ml) were then carried out in duplicate for samples with less than 60% of control values in the initial screen.
Cells were seeded into 96 well microplates at a density of 0.5 x 10 4 cells/well in 100µl Dulbecco's modified Eagle's medium (DMEM; Invitrogen) and incubated at 37ºC, 5% CO 2 with a humidified atmosphere for 24 hours. After which DMEM solutions of test compounds at the desired concentrations and DMSO as a negative control and 0.1% Triton X as a positive control were added to give a total well volume of 200µl. The microplates were incubated for 24 hours before the addition of 10µl of alamar blue. After a further 20 hours incubation fluorescence was determined using a Wallac Victor microplate reader in fluorescence mode (Excitation 530nm; Emission 590nm). The results were calculated as % of the DMSO control values. IC 50 values were calculated for the concentration response data using Graphpad prism software.
Isolation and structure elucidation of compounds
Melting points (uncorr.) were determined on a Buchi B-540 melting point apparatus. The 1 H NMR and 13 C NMR spectra were run on a Bruker AV 300 (400MHz) and DRX 500 spectrometers using CDCl 3 or DMSO-d6 as solvents and TMS as internal standard. HRESI-MS were run using Thermo LTQ Orbitrap or Thermo Exactive orbitrap mass spectrometer. A capillary voltage of 46.00V for the positive mode and -48.00V for the negative mode was used for HRESI-MS. Column chromatography were performed using silica gel MN-60 (Macherey-Nagel GmbH & Co. KG) and Gel filtration chromatography using Sephadex LH-20 (GE Health Lifescience UK) were performed in glass columns. Spots on TLC were visualised using Anisaldehyde-H 2 SO 4 reagent or Dragendorff's reagent for the alkaloids. Developed TLC plates were also observed under UV lamp using short (λ= 254 nm) and long (λ= 366 nm) wavelengths. The structures of the pure compounds were determined using spectroscopic methods (1D/2D NMR and mass spectrometry). Column chromatography (CC) were carried out on wet packed silica gel in glass columns eluting gradient wise with hexane, hexane-ethyl acetate, ethyl acetate and ethyl acetate-methanol mixtures or with Sephadex LH-20 pre-soaked and wet packed in methanol. After the introduction of the extracts or fractions in methanol, the Sephadex columns were also eluted with methanol. TLC analysis was performed on pre-coated silica gel aluminum plates cut to desired size. NMR experiments were run in CDCl3 or DMSO-d6 with TMS as internal standard on Bruker AV 300 (400MHz) or DRX-500 spectrophotometer.
Plant materials
All plant materials were collected from Oju LGA Benue State, Nigeria between July and September 2008. The plants were authenticated by the Department of Forestry and Wildlife of the University where voucher specimens were deposited in the University of Agriculture Forest Herbarium. Alcornea cordifolia (bark), Euphorbia poisonii (stem), Monodora myristica (seeds), Prosopis Africana (bark), Spondias mombim (root), Nauclea pobeguinii (bark), Nauclea latifolia (bark), Cochlospermum planchonii(root) and Withania somnifera (whole plant), Terminalia avicennioides (bark). Maytenus laevis (root) was from samples already housed at the Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS). They were all sun dried in open air and ground using a mill.
Extraction and identification of the components
The plant materials (500g -1.0kg) were air dried and extracted using hexane, ethyl acetate and methanol in a Soxhlet apparatus. The crude extracts were allowed to stand and sometimes cooled to allow for the precipitation of compounds. Where all precipitates have been produced or no (further) precipitation, the crude extracts or precipitates (where not a pure compound) were subjected to column chromatography (CC) eluting gradient-wise using hexane-ethyl acetate and subsequently ethyl acetate-methanol solvent mixtures. Using TLC as a guide, similar fractions were combined and allowed to evaporate under the fume hood to allow for the crystallisation of pure compounds. Where no pure compounds were separated and the fractions were active, such fractions were further purified via preparative thin layer chromatography or Gel filtration (GF) using Sephadex LH-20 to obtain the pure compounds. Methanol extracts which were usually viscous and complex were subjected to an initial vacuum liquid chromatography (VLC) to fractionate the extracts. Similar fractions (TLC) were also combined and further purified via column chromatography or Gel filtration. Flash chromatography using an iES Reveleris Automated Flash Chromatography system was used for the isolation of certain compounds. The column was dry packed after taking up the extracts with silica gel and then loaded onto the pre-packed flash column. The compounds were eluted starting with hexane with incremental additions of ethyl acetate, then with ethyl acetate with additions of methanol and finally with methanol. Using two variable length UV detectors and one ELSD detector, similar eluates were combined and confirmed by TLC and 1 H NMR. Pure compounds were then allowed to settle out from the combined fractions. All columns were exhaustively eluted and washed with methanol. Washings were allowed to stand to allow for the precipitation of compounds. The identification of pure compounds was carried out using one dimensional 1 H and 13 C NMR spectroscopy (including J-mod, DEPT-q and DEPT 135 or 90). Spectral data of known compounds were compared with published spectral data and were thereby identified. Further 2D experiments (including correlation spectroscopy (COSY), heteronuclear multiple quantum coherence (HMQC), heteronuclear multiple bond correlation (HMBC) and nuclear overhauser enhancement spectroscopy (NOESY)) were carried out for more complex molecules for accurate assignments of proton and carbon chemical shifts. Assigned structures were confirmed using ESI-MS and HRESI-MS to confirm their mass and molecular formula. The various extracts produced are listed in table 3 below. Extract code descriptions or extensions are: precipitate (P), latex (L), Sephadex (S), methanol wash (w), VLC fraction (V), flash chromatography fraction (F), root (R), bark (B).
Results

Anti-trypanosomal screening
The photographs below show the results from the concentration response studies to determine the MIC of the triterpenoids (compounds 11 and 12) from M.laevis. Well A1 is the sterility check, wells B1 to H1 negative controls and wells G2 to G11 and H2 to H11 are the DMSO 1:1 dilution controls. Column 12 contains a concentration range of 1 to 0.008µM of the positive control suramin. In plate 1 compounds 11 (rows C and D) and 12 (rows E and F) are tested n=2 over a concentration range of 100 to 0.17µM. In plate 2 compounds 11 (rows A, B and C) and 12 (rows D,E and F) are tested n=3 over a concentration range of 10 to 0.02µM. (Paveto et al., 2004) . The stem of E. poisonii afforded the steroidal triterpene and scoporone. The caffeic acid esters were isolated from A.cordifolia and there could be a mixture of more esters. The quinonemethide friedelene triterpenes were obtained from hexane and ethyl acetate extracts of M. laevis. They showed very good activity with MICs of 0.625µg/ml. Other pure compounds obtained are as listed on table 2. Some of the pure compounds were however not active when tested. Compound 13 is one of such as well as compound 14 which did not show very good activity. The results of these screening supports a further investigation of the active compounds identified. These could be confirmed as hit molecules especially when the compound's cytotoxicity is low showing selectivity which is vital for drug molecules. Compounds that are inimical to the growth and survival of microorganisms but do not affect the cells adversely are potential candidate s for dru g develo pment. Some of the extracts and fractions show significant activity but the active compounds have not been identified in this study. Such extracts could be subject of further investigation to isolate or identify the active components. These results also lend credence to some of the ethnobotanical or traditional use of the plants as they are mainly used against fevers caused by malarial parasites. Interestingly, the same or similar compounds were isolated from the different plant samples. Some belong to the same families but others do not. This thus confirms their activity not being due to the crude extracts or fractions but the fact that these extracts or fractions contain the same or similar compounds. These results may easily pave way for a structure activity study as variations in structure and side chains or substituents on similar moieties vis-à-vis activity can easily be observed. For instance it can be observed that glycosidation knocks off activity from the test compounds.
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